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Surprisingly, whereas for a long time Por2 was not considered to
have a channel activity [6], mitochondria from ΔPOR1 strain imported
signiﬁcant amount of tRK1 in presence of cytb2-DHFR. Experiments
with vesicles prepared from outer membrane of wild type and
ΔPOR1,2mitochondria conﬁrmed the essential role of Por2 protein in
tRK1 import. Finally, ﬁrst time isolated homogenous Por2 was
reconstituted into small unilamellar vesicles and planar phospholipid
bilayer membranes. With proteoliposomes it was shown that Por2
provides transport of carbohydrates and nucleotides across the
membrane with the same kinetic as for Por1 and on bilayer system
cation selective channels were registered with conductivity about
2 nS and closure with voltage above 30 mV in pH dependent manner.
Physiological role of Por2 and downregulation mechanism of its
channel activity in mitochondrial outer membrane are discussed.
An understanding of the ﬁne mechanisms of tRNA import from
cytosol could help us to improve delivery of “therapeutic” RNA
molecules into mitochondria to cure at themolecular level the negative
effects of mutations of tRNA genes coded by the mitochondrial DNA
causes large number of human diseases, such as Mitochondrial
Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)
or Myoclonic Epilepsy with Ragged Red Fibers (MERRF) [7].
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The growth factor adaptor protein, p66Shc, has a substantial
impact on mitochondrial metabolism through regulation of cellular
response to oxidative stress [1]. Low level of the p66Shc protein or its
complete ablation protects against numerous age-related disorders
and may partially prevent pathologies caused by reactive oxygen
species (ROS). On the other hand, high level of p66Shc has been
correlated with increased intracellular ROS production [2].
In our studies we have shown that both extracellular and intra-
cellular oxidative stresses can trigger phosphorylation of p66Shc at
Ser36 leading to increased ROS production. Fibroblasts derived from
patients with deﬁned variousmitochondrial disorders have been used
as a model of a self-propelling intracellular oxidative stress. Detailed
characterization of bioenergetic parameters and ROS production in
cells harboring mitochondrial defects showed that ﬁbroblasts from
patients demonstrate an increased ROS production compared to
control cells. We have also observed alterations in the antioxidant
defense system, decreased levels of electron transfer chain complexes
and attenuated oxidative chain activity of the patient cells. Observed
mitochondrial dysfunctions correlated with the increased status of
p66Shc phosphorylation at Ser36. In order to decrease the global and
p66Shc-related ROS generation in patient cells we tested a series of
chemical compounds demonstrating antioxidant capacities (with
different intracellular localization and speciﬁcity for different ROS
molecules) as well as kinase inhibitors (targeted against kinases
involved in the p66Shc phosphorylation at Ser36).
Alterations in the p66Shc phosphorylation pathways or adminis-
tration of mitochondrially targeted antioxidants seems to be a
promising way to stop the vicious circle of ROS induced p66Shc
phosphorylation‐related ROS production. This approach may open
new possibilities for pharmacological interventions that could
minimize the cellular effects of p66Shc phosphorylation in case of
pathological intracellular oxidative stress.
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Neoplasias uncouple anabolic glucose utilization from oxygen
availability to sustain unrestrained growth when oxygen and
nutrients are scarce, but the concomitant decrease in mitochondrial
respiration potentially exposes cancer cells to oxidative stress. We
report that the mitochondrial chaperone TRAP1, which is induced in
most tumor types, is required for neoplastic growth, and confers
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transforming potential to non-cancerous cells. TRAP1 binds to and
inhibits succinate dehydrogenase (SDH), the complex II of the
respiratory chain. The respiratory down-regulation elicited by TRAP1
interaction with SDH promotes tumorigenesis both by minimizing
oxidative damage, as it abrogates ROS generation by SDH and the
ensuing lethal opening of the mitochondrial permeability transition
pore; and by priming the succinate-dependent stabilization of the
pro-neoplastic transcription factor HIF1α. These ﬁndings provide a
mechanistic clue to explain the switch to aerobic glycolysis of tumors,
and identify TRAP1 as a promising anti-neoplastic target.
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Creatine kinase (CK) and hexokinase (HK) play a key role in the
energy homeostasis of cardiac cells. Mitochondrial CK (mtCK) and
two hexokinase isoforms (HK1 and HK2) strongly support mitochon-
drial oxidative phosphorylation by increasing the availability of ADP
for complex V of the respiratory chain and lower the probability of
MPT pore opening. Besides mitochondrial isoform, there are two
cytosolic CKs (CKM and CKB) present in cardiomyocytes. The purpose
of this study was to determine CK and HK expression and their
activity in rat hearts adapted to chronic hypoxia under three different
protocols of adaptation. Two of them, continuous normobaric hypoxia
(CCH) and intermittent normobaric hypoxia (INH), are known as
cardioprotective adaptations. The third one, CCH with daily 1-h
reoxygenation (CCH-R), abolishes cardiprotective effect. Adult male
Wistar rats were exposed for 21 days to a 10 % oxygen atmosphere in
a normobaric chamber. The expression of CK and HK was determined
in the left ventricular myocardium using Real Time PCR and Western
blotting. The enzyme activities were assessed by an enzyme-coupled
assay. All hypoxic adaptations increased the total speciﬁc CK activity
by about 80%. The protein and mRNA levels of mtCK and CKB
signiﬁcantly increased but CKM levels remained unchanged. In
contrast to HK2, the level of mRNA as well as protein of HK1 and
HK2 increased, but the total speciﬁc HK activity remained unchanged.
This data demonstrate complementation of cytosolic CKM with CKB
and a concomitant increase in enzyme capacity of mitochondrial CK
under hypoxic conditions. In this way, mtCK and HKs can more
efﬁciently stimulate the respiratory chain and reduce possible ROS
production. It seems that CK and HK isoforms do not play a major role
in the preclusion of the development of cardioprotection observed in
CCH-R adaptation. The possible participation of these enzymes in the
mechanism of hypoxia-induced cardioprotection remains unclear.
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